High level summaries of key studies and emerging evidence, reviewed regularly and updated as soon as new evidence and information is published.
A rapid review outlining the available evidence on a discrete topic or question relating to the current COVID-19 pandemic. Evidence includes grey and peer review literature.
Recently published or updated
- Bivalent COVID-19 vaccines (PDF 213 KB)
- Molnupiravir (PDF 241 KB)
- Surgery post COVID-19 (PDF 208 KB)
- Paxlovid (PDF 191 KB)
Risk monitoring dashboard
A dashboard focusing on transmission risk in healthcare settings. The dashboard brings together data on cases, clusters, the public health response, and the impact of COVID-19 on the workforce. An expert panel reviews the dashboard and assigns a risk rating. For details on infection prevention and control recommendations, please refer to the CEC framework. Please note, the dashboard will be updated on a fortnightly basis from 28 September 2022.
A summary of new evidence and reports from international sources. From 27 May, the digest will be produced on a weekly basis.
Subscribe to the evidence digest by emailing NSWH-CriticalIntelligenceUnit@health.nsw.gov.au
The COVID-19 Monitor provides a snapshot of topical data and graphs – drawn from international and national sources. The content changes in line with emerging themes and current areas of debate and discussion.
The CIU Intelligence Brief is a report that focuses on key issues in health. It draws on a range of different types of evidence – research, data and experiential.
About the CIU
The NSW Health Critical Intelligence Unit provides rapid, evidence-based insights during the COVID-19 pandemic. Its operations focus on systems intelligence, clinical intelligence and evidence integration.
If you have a question or would like to contact the Critical Intelligence Unit please email: NSWH-CriticalIntelligenceUnit@health.nsw.gov.au
Enquiries from journalists please email: ACI-Media@health.nsw.gov.au